NCT07100990 2026-03-11
TIMELY-PLEX
Mayo Clinic
Phase 3 Recruiting
Clinical Trials
20 trialsNCT06147258 2025-12-24
The Impact of Expressive Emotional Writing on Facilitating Grief Resolution in Adults With Spinal Cord Injury
University of Alabama at Birmingham
Phase NA Recruiting
NCT04201262 2025-10-14
An Efficacy and Safety Study of Ravulizumab in Adult Participants With NMOSD
Alexion Pharmaceuticals, Inc.
Phase 3 Completed
NCT04564495 2025-02-05
Telex
Burke Medical Research Institute
Phase NA Active not recruiting
NCT04155424 2024-09-25
A Study of the Safety and Activity of Eculizumab in Pediatric Participants With Relapsing Neuromyelitis Optica Spectrum Disorder
Alexion Pharmaceuticals, Inc.
Phase 2/3 Terminated
NCT05491525 2024-07-03
KANGUROO
Urovant Sciences GmbH
Phase 2/3 Recruiting
NCT03887273 2023-08-21
Study to Investigate the Safety of the Transplantation of Human Glial Restricted Progenitor Cells Into Subjects With Transverse Myelitis
Q Therapeutics, Inc.
Phase 1/2 Unknown
NCT02003144 2022-08-23
An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients
Alexion Pharmaceuticals, Inc.
Phase 3 Completed
NCT05249595 2022-02-21
Ultrasound Imaging Based Sensing of Human Ankle Motion Intent and Control Strategies for Ankle Assistance
North Carolina State University
Phase NA Unknown
NCT00304291 2020-12-28
A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic's Disease)
State University of New York at Buffalo
Phase 4 Completed
NCT02591901 2020-03-18
PReSuTINeB
Buckinghamshire Healthcare NHS Trust
Phase 2 Completed
NCT01892345 2019-06-26
A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study)
Alexion Pharmaceuticals, Inc.
Phase 3 Terminated
NCT02276963 2019-06-06
Ublituximab for Acute Neuromyelitis Optica (NMO) Relapses
Johns Hopkins University
Phase 1 Completed
NCT02341950 2019-02-22
Clinical Trial of a Serious Game for Individuals With SCI/D
University of Michigan
Phase NA Completed
NCT03138421 2019-01-25
Central Pain Study for ABX-1431
Abide Therapeutics
Phase 1 Completed
NCT02166346 2018-04-17
Safety and Efficacy of Sustained Release Dalfampridine in Transverse Myelitis (Re-Launch)
Johns Hopkins University
Phase 2 Completed
NCT00179478 2017-09-06
CHAMPIONS10
Beth Israel Deaconess Medical Center
Phase 4 Completed
NCT02398994 2016-07-20
STRIVE
Guy's and St Thomas' NHS Foundation Trust
Phase 3 Terminated
NCT00501748 2011-09-27
Safety and Tolerability of Rituximab in Neuromyelitis Optica
University of California, San Francisco
Phase 1 Completed
NCT00004645 2005-06-24
Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone
Office of Rare Diseases (ORD)
Phase 3 Unknown